Quetmolimab: A Deep Dive into KANAb 001 and E-6011 The agent, quetmolimab, shows a new approach aimed at programmed cell death protein 1. First clinical data from the two studies, KANAb 001 and E-6011, reveal https://socialmediainuk.com/story26734947/text